
From lab to mice: nanodrug offers hope for ulcerative colitis treatment
Debraj Manna
In a collaborative study, researchers from the SN Bose National Centre for Basic Sciences, Kolkata, Uluberia College, University of Calcutta, and other institutes made an exciting discovery in treating ulcerative colitis, a prevalent chronic inflammatory bowel disease (IBD). By using chitosan-capped trimanganese tetraoxide nanoparticles, they effectively treated the disease in mice, offering the potential for future therapeutic advancements in this debilitating condition.